PEG300 [25322-68-3]
Katalog-Nummer HY-Y0873-50mL
Size : 50mL
Marke : MedChemExpress
Contact local distributor :
Telefonnummer : +1 850 650 7790
PEG300 (Polyethylene glycol 300), a neutral polymer of molecular weight 300, is a water-soluble, low immunogenic and biocompatible polymer formed by repeating units of ethylene glycol.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
PEG300 Chemische Struktur
CAS. Nr. : 25322-68-3
* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.
- •Cell. 2021 Sep 2;184(18):4753-4771.e27. [Abstract]
- •Nat Microbiol. 2023 Jan;8(1):121-134. [Abstract]
- •J Hepatol. 2023 Jan 18;S0168-8278(23)00015-6. [Abstract]
- •Nat Commun. 2023 May 24;14(1):2994. [Abstract]
- •Nat Commun. 2023 May 19;14(1):2859. [Abstract]
- •Nat Commun. 2021 May 10;12(1):2587. [Abstract]
- •Cancer Res. 2021 Jan 25;canres.2808.2020. [Abstract]
- •Biomark Res. 2023 Jan 24;11(1):8. [Abstract]
- •Proc Natl Acad Sci U S A. 2022 Oct 11;119(41):e2203480119. [Abstract]
- •Cell Rep. 2023 Apr 20;42(5):112424. [Abstract]
- •Cell Rep. 2023 Mar 30;42(4):112314. [Abstract]
- •Phytomedicine. 2022, 154638.
- •Aging Cell. 2023 Jun 13;e13896. [Abstract]
- •Biomed Pharmacother. 2023, 157: 114030.
- •Biomed Pharmacother. 2022 Sep 13;155:113669. [Abstract]
- •Neurobiol Dis. 2023 Mar 28;106103. [Abstract]
- •Neural Regen Res. 2022.
- •Food Funct. 2020 Dec 15.
- •iScience. 13 August 2022, 104936.
- •iScience. 2022 Apr 18;25(5):104267. [Abstract]
- •Int J Mol Sci. 2023 Jun 9, 24(12), 9954.
- •Neurosci Bull. 2023 Jun 15. [Abstract]
- •Int Immunopharmacol. 2023, 114: 109607.
- •Int Immunopharmacol. 2022 Jun 28;110:109000. [Abstract]
- •Front Pharmacol. 13 September 2021.
- •J Ethnopharmacol. 2021, 114078.
- •J Cell Mol Med. 2021 Jun;25(12):5782-5798. [Abstract]
- •Int J Obes. 2023 Feb 13;1-10. [Abstract]
- •J Neurochem. 2021 Jul 13. [Abstract]
- •Pharmaceuticals. 2023, 16(2), 316.
- •Bone. 2022 Dec 21;168:116648. [Abstract]
- •Arch Biochem Biophys. 2022 Jun 21;727:109325. [Abstract]
- •Mol Immunol. 2023 Apr 10;157:176-185. [Abstract]
- •Front Cardiovasc Med. 2022 Jun 2;9:907747. [Abstract]
- •Mol Imaging Biol. 2022 Jun 22. [Abstract]
- •J Pain Res. 2021 Oct 18;14:3289-3299. [Abstract]
- •FEBS Open Bio. 2022 Jun 24. [Abstract]
- •Epilepsy Res. 2023 Jul, 193, 107161.
- •University of Michigan. 2023 Sep.
- •Research Square Preprint. 2023 Sep 8.
- •Western University. 2023 Aug 22.
- •Research Square Preprint. 2023 Jun 28.
- •Universidad de Granada. 2023 Mar 27.
- •Research Square Print. 2023 Mar 23.
- •Research Square Print. 2022 Aug.
Biologische Aktivität
Reinheit & Dokumentation
Verweise
Kundenbewertung
| PEG300 (Polyethylene glycol 300), a neutral polymer of molecular weight 300, is a water-soluble, low immunogenic and biocompatible polymer formed by repeating units of ethylene glycol. | |
| In Vitro | The FDA has approved polyethylene glycol (PEG) for use as a vehicle or base in foods, cosmetics and pharmaceuticals, including injectable, topical, rectal and nasal formulations. PEG shows little toxicity, and is eliminated from the body intact by either the kidneys (for PEGs < 30 kDa) or in the faeces (for PEGs > 20 kDa). PEG lacks immunogenicity, and antibodies to PEG are generated in rabbits only if PEG is combined with highly immunogenic proteins. MCE has not independently confirmed the accuracy of these methods. They are for reference only. |
|---|